Qiagen, a biotechnology firm, said 2Q adjusted EPS is expected to rise 68% on year at constant exchange rate to 0.55 - 0.56 dollar, compared with its prior guidance of at least 0.40 dollar, and net sales are estimated to grow 18% - 19% at constant exchange rates, compared with previous forecast of at least 12% growth.
From a chartist point of view, the stock price is trading above its upper Bollinger band thanks to the bullish gap opened this morning. Prices are supported by the rising 20- and 50-day simple moving averages. However, on a weekly chart, a rising wedge pattern is taking shape, calling for caution. Prices need to stand above 37.7E to maintain the bullish bias. Next resistance thresholds are set at 41E and 42.8E. Alternatively, a break below 37.7E would call for a reversal down trend with 34E as target.
Source: GAIN Capital, TradingView
